Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes
In pregnant individuals with aPL, with or without SLE, aD1 and antiphosphatidylserine-prothrombin IgG are significant independent predictors of adverse pregnancy outcomes and are strongly associated with lupus anticoagulant. Combined use may identify patients at greatest risk for severe obstetric complications.
Authors
- Ashley E. Benson (ORCID: https://orcid.org/0000-0001-5716-2818)
- Amanda A. Allshouse (ORCID: https://orcid.org/0000-0003-0109-7193)
- Lisa K. Peterson (ORCID: https://orcid.org/0000-0001-8702-1311)
- Kimberly Moyle (ORCID: https://orcid.org/0000-0002-9424-6110)
- Marta Guerra (ORCID: https://orcid.org/0000-0003-1698-6209)
- D. Ware Branch (ORCID: https://orcid.org/0000-0002-1718-5094)
- Jane E. Salmon
Institutions
- Orthopedic Specialty Hospital (US)
Publication Details
- Journal
- Obstetrics and Gynecology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1097/aog.0000000000005729
- Citations
- 4
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- Foundation for the National Institutes of Health
- National Institutes of Health
- Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Center for Advancing Translational Sciences
- UCB Pharma